Get started
Author

Dimitrios Siatis

Observed names: D Siatis, D. Siatis
ORCID: 0000-0002-4749-5624
Observed ORCID: 0000-0002-4749-5624
OpenAlex ID: A5000757277
Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2011 · Francesco Galimi, Davide Torti, et al. · Clinical Cancer Research · 125
PDF
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour
2017 · Lorenzo D'Ambrosio, Erica Palesandro, et al. · European Journal of Cancer · 38
Surgical treatment of primary melanoma of the umbilicus with sentinel lymph node biopsy and plastic reconstruction: Case report and review of the literature
2010 · A. Zaccagna, D. Siatis, et al. · European Journal of Surgical Oncology · 16
Transperitoneal laparoscopical iliac lymphadenectomy for treatment of malignant melanoma
2003 · F. Picciotto, E. Volpi, et al. · Surgical Endoscopy · 16
Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.
2014 · M Robella, M Vaira, et al. · PubMed · 14
Innovating Sarcoma Education: Early Outcomes of the Italian Society of Surgical Oncology (SICO) Sarcoma Social Multi-Platform Journal Club Initiative
2025 · L. Samà, C. Pagnoni, et al. · European Journal of Surgical Oncology
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report
2023 · L. Zumstein, V. Tuninetti, et al. · Gynecologic Oncology Reports
Supplementary Figure S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Materials and Methods from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023 · Francesco Galimi, Davide Torti, et al.
Impact of upfront multidisciplinary tumor board (MTB) evaluation on breast sarcoma (BS) outcome.
2020 · Francesco Tolomeo, Giovanna Chilà, et al. · Journal of Clinical Oncology
Adherence to guidelines and quality of treatment of retroperitoneal sarcomas: A retrospective regional analysis in Italy
2018 · A. Ponzetti, C. Gianotti, et al. · European Journal of Surgical Oncology
905 Pelvic exenteration for locally advanced cancer of the pelvis: Short and long term results according to tumor location
2015 · S. Sandrucci, D. Siatis, et al. · European Journal of Cancer
Technical and Clinical Description of a Case of Extensive Anogenital Paget's Disease Associated with anal Cancer Treated by Tomotherapy
2014 · Elisabetta Garibaldi, Gabriella Cattari, et al. · Tumori Journal
Works count: 29
Citation count: 208
H-index: 5
I10-index: 5
Year
Topic
Type